Florence Broussais

Pierre-la-treiche, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

Journal: HemaSphere

Published: April 29, 2025

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Journal: HemaSphere

Published: March 20, 2025

Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere

Published: March 13, 2025

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.

Journal: Blood

Published: May 09, 2022

Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France.

Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France.

Journal: EClinicalMedicine

Published: May 05, 2022

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

Journal: Nature medicine

Published: March 29, 2022

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 11, 2022

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 11, 2022

Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].

Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 16, 2021

A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Journal: Bulletin du cancer

Published: January 25, 2021

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.

Journal: Blood advances

Published: February 10, 2018

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 19, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026